NAYA Biosciences Inc. (NAYA)
0.38
0.01 (2.70%)
At close: Mar 03, 2025, 3:59 PM
0.39
2.82%
After-hours: Mar 03, 2025, 05:19 PM EST
NAYA Biosciences Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY10 | FY09 | FY08 | FY07 |
| Net Income | -8.03M | -10.89M | -6.65M | -8.35M | -2.17M | -3.08M | -702.16K | -2.12M | -4.96M | -153.43K | -4.66M | -1.87M | -214.09K |
| Depreciation & Amortization | 200.89K | 77.3K | 166.08K | 34.48K | 25.35K | 5.19K | 2.81K | 1.88K | 5.63K | 14.04K | 14.04K | 7.51K | 6.15K |
| Stock-Based Compensation | 1.39M | 2.22M | 2.71M | 1.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -452.98K | 580.49K | -3.67M | -624.79K | 2.99M | 460.79K | 325K | 473.29K | 388.8K | 721.08K | 144.46K | 479.35K | -11.62K |
| Other Non-Cash Items | 1.21M | 505.43K | 1.36M | 2.63M | 564.7K | 2.46M | 256K | 1.26M | 4.42M | -830.87K | 3.11M | 216.09K | 93.16K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 433.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 471.7K | 1.48M | -3.61M | -845.52K | 2.95M | -40.86K | 262.08K | 534.87K | 378.52K | 654.26K | 608.13K | 583.17K | -1.27K |
| Operating Cash Flow | -4.76M | -6.6M | -6.03M | -4.78M | 1.37M | -652.97K | -181.27K | -323.9K | -151.62K | -315.99K | -926.66K | -1.07M | -116.04K |
| Capital Expenditures | -444.72K | -12.73K | -454.65K | -88.93K | -64.84K | -19.4K | n/a | -15.7K | 2.00 | 2.00 | 4.00 | -42.86K | 1.00 |
| Acquisitions | -2.05M | -68.49K | -1.7M | -98.08K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -1.94K | -38.94K | -39.91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -2.49M | -81.22K | -2.15M | -187.25K | -114.71K | -19.4K | n/a | -15.7K | n/a | n/a | n/a | -73.88K | -46.73K |
| Debt Repayment | 1.66M | 800K | -250K | 2.35M | -229.47K | 781.86K | n/a | n/a | -20K | -25K | 595K | 74.28K | 142.77K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 25.43K | n/a | 369.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 7.39M | 1.09M | 3.77M | 13.82M | -229.47K | 858.86K | 54.63K | n/a | 625K | 249.47K | 990K | 1.16M | 162.77K |
| Net Cash Flow | 142.29K | -5.59M | -4.41M | 8.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Free Cash Flow | -5.2M | -6.62M | -6.48M | -4.86M | 1.31M | -672.37K | -181.27K | -339.6K | -151.62K | -315.99K | -926.66K | -1.11M | -116.04K |